http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bc0de016ae2b6a326f81c67d96782bdc
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Anderson |
| name | Kenneth Anderson |
| given-name | Kenneth |
| organization-name | Department of Hematology/Oncology, Dana-Farber Cancer Institute, Boston, MA; Department of Pathology, The University of Chicago, Chicago, IL 60637 Department of Chemistry and Biochemistry, North Dakota State University, Fargo, North Dakota 58102, United States Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Jerome Lipper Multiple Myeloma Center, Division of Hematologic Neoplasia, Harvard Medical School, and Dana-Farber Cancer Institute, Boston, MA From the Divisions of Hematologic Malignancies and Biostatistics, Dana-Farber Cancer Institute, and the Joint Center for Radiation Therapy, Harvard Medical School, Boston, MA. Dana-Farber Cancer Institute, Boston, MA; American Society of Clinical Oncology, Alexandria, VA; Mayo Clinic, Rochester, MN ROSWELL PARK CANCER INSTITUTE; DUKE UNIVERSITY MEDICAL CENTER; DANA-FARBER CANCER INSTITUTE Dana-Farber Cancer Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA Division of Hematologic Oncology Dana‐Farber Cancer Institute Boston MA USA 3Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA Department of Medical Oncology, Dana-Farber Cancer Institute, From the Center for Hematologic Oncology and Department of Biostatistics, Dana-Farber Cancer Institute, Departments of Medicine and Radiation Therapy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. Jerome Lipper Multiple Myeloma Center, Division Of Hematologic Neoplasia, Kraft Family Professor of Medicine, Harvard Medical School, and Dana-Farber Cancer Institute, Boston, MA Department of Respiratory Medicine, Crosshouse Hospital, Ayrshire KA2 0BE From the Division of Hematologic Malignancies and Biostatistics, Dana-Farber Cancer Institute, Boston, MA; the Department of Radiation Therapy, Brigham and Women's Hospital, Boston, MA; and the Departments of Medicine and Radiation Oncology, Harvard Medical School, Boston, MA. 5Dana-Farber Cancer Institute, Boston, Massachusetts. Jerome Lipper Myeloma Center, Division of Hematologic Oncology, Department of Adult Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115; Jerome Lipper Multiple Myeloma Center, LeBow Institute for Myeloma Therapeutics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA Dana Farber Cancer Institute, Boston, Massachusetts 02115; Chief Resident, Touro University-Nevada College of Osteopathic Medicine/Valley Hospital Medical Center, Las Vegas, NV. Department of Chemistry and Biochemistry, North Dakota State University, Fargo, North Dakota 58108, United States Department of Medical Oncology Dana‐Farber Cancer Institute Boston MA USA Meletios A. Dimopoulos and Evangelos Terpos, National and Kapodistrian University of Athens School of Medicine, Athens, Greece; Jens Hillengass and Hartmut Goldschmidt, University Hospital Heidelberg, Heidelberg, Germany; Saad Usmani, Carolinas Healthcare System, Charlotte, NC; Elena Zamagni and Michele Cavo, Bologna University School of Medicine, Bologna; Antonio Palumbo, S. Giovanni Battista Hospital, University of Turin, Turin, Italy; Suzanne Lentzsch, Columbia University College of Physicians and... Dana-Farber Cancer Institute, Boston, MA; and Presented by Kenneth Anderson, MD, Kraft Family Professor of Medicine, Harvard Medical School, Director, LeBow Institute for Myeloma Therapeutics, and Director, Jerome Lipper Multiple Myeloma Center, Dana-Farber/Brigham and Women’s Cancer Center, Boston, Massachusetts. Department of Medicine, Harvard Medical School and Kraft Family Blood Center, Dana-Farber Cancer Institute, Boston, Massachusetts, USA Authors' Affiliations: 1Department of Medical Oncology; 2Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute; 3Harvard School of Public Health; 4Department of Pathology, Brigham & Women's Hospital; 5Department of Developmental Biology, Harvard School of Dental Medicine; 6Center for Advanced Orthopaedic Studies, Beth Israel Deaconess Medical Center, Boston, Massachusetts; and 7Experimental Therapies, H. Lee Moffitt Cancer Center, Florida; and 8Department of Bioinformatics, School of Life Science and Technology, Tongji University, Shanghai, China; Authors' Affiliations: 1Department of Medical Oncology; 2Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute; 3Harvard School of Public Health; 4Department of Pathology, Brigham & Women's Hospital; 5Department of Developmental Biology, Harvard School of Dental Medicine; 6Center for Advanced Orthopaedic Studies, Beth Israel Deaconess Medical Center, Boston, Massachusetts; and 7Experimental Therapies, H. Lee Moffitt Cancer Center, Florida; and 8Department of Bioinformatics, School of Life Science and Technology, Tongji University, Shanghai, China From Analysis Group/EconomicsCambridge, and Dana-Farber Cancer Institute, Boston, MA; Université du Québec à Montréàl, Montreal, Canada; and Ortho Biotech, Inc, Raritan, NJ. Manchester Royal Infirmary, Manchester, UK. Dana‐Farber Cancer Institute Boston MA USA Kenneth Anderson, Dana-Farber Cancer Institute; Noopur Raje, Massachusetts General Hospital, Boston, MA; Nofisat Ismaila, American Society of Clinical Oncology, Alexandria, VA; Patrick J. Flynn, Minnesota Oncology, Woodbury; Robert A. Kyle, Mayo Clinic, Rochester, MN; Susan Halabi, Duke University Medical Center, Durham, NC; Sundar Jagannath, Mount Sinai Medical Center, New York, NY; Mohammed S. Ogaily, Beuamont Center for Hematology and Oncology–Downriver, Brownstown, MI; Jim Omel, Education and... Dana‐Farber Cancer Institute Boston Massachusetts USA Philippe Moreau, Florence Caillon, Caroline Bodet-Milin, Aurelie Gaultier, Jean-Michel Nguyen, Benoit Dupas, Eric Frampas, and Françoise Kraeber-Bodere, University Hospital, Nantes; Michel Attal, University Hospital, Toulouse; Denis Caillot, University Hospital, Dijon; Margaret Macro, University Hospital, Caen; Lionel Karlin, University Hospital, Lyon; Laurent Garderet, University Hospital Saint-Antoine, Paris; Thierry Facon, University Hospital, Lille; Lotfi Benboubker, University Hospital, Tours;... a Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA From the Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and the Department of Microbiology, Jikei University School of Medicine, Tokyo, Japan. Authors' Affiliations: 1Beth Israel Deaconess Medical Center; 2Dana Farber Cancer Institute; 3Massachussetts General Hospital, Boston, Massachusetts; and 4Rambam Medical Center, Haifa, Israel 1Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Department of Medical Oncology, The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts |
Incoming Links
Total number of triples: 161.